ClotCare: Blood Clots, Stroke, Heart Attack
Saturday, June 24, 2017
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

Antithrombotic Therapy Survey

Updated September, 2005

Institute for Safe Medication Practices

1800 Byberry Road, Suite 810, Huntingdon Valley, PA 19006
www.ismp.org

FOR IMMEDIATE RELEASE
August 11, 2005
CONTACT: Renee Brehio, Media Relations
704-321-3343, rbrehio@ismp.org

Deadline Extended for ISMP Antithrombotic Self Assessment Survey

Huntingdon Valley, PA - To capture the most complete data set possible, the Institute for Safe Medication Practices (ISMP) is giving hospitals more time to participate in its new self assessment of antithrombotic therapy. Those hospitals that have not been able to complete the assessment should be aware that ISMP has extended the data submission deadline to March 1, 2006.

The self assessment is designed to help healthcare organizations examine medication safety practices associated with the prescribing, dispensing, administration, and monitoring of antithrombotic drugs in their facilities. Participants gain the unique opportunity to compare their data with aggregate data from other demographically similar hospitals and identify potential areas of improvement in the use of these high alert drugs.

All hospital pharmacy directors in the U.S. have been mailed a self assessment workbook and instructions; results can be submitted online. For more information or questions about the self assessment, contact ISMP at selfassess@ismp.org.

About ISMP: The Institute for Safe Medication Practices (ISMP) is a 501c(3) nonprofit organization that works closely with healthcare practitioners and institutions, regulatory agencies, consumers, and professional organizations to provide education about medication errors and their prevention. ISMP represents nearly 30 years of experience in helping healthcare practitioners keep patients safe, and continues to lead efforts to improve the medication use process. In 2004, the Institute is celebrating the 10th anniversary of is official incorporation as a nonprofit organization. For more information on ISMP, or its medication safety alert newsletters for healthcare professionals and consumers, visit www.ismp.org.


Original Posting

July, 2005

The Institute for Safe Medication Practices (ISMP) has informed us that they are distributing a survey to hospitals across the US that will "...help healthcare organizations examine medication safety practices associated with the prescribing, dispensing, administration, and monitoring of antithrombotic drugs...." Participants will have the opportunity to compare their scores with demographically similar hospitals. For more information, please refer to the press release below from the ISMP. Within the press release, you will find contact information for the ISMP and a link to their website.

Institute for Safe Medication Practices

1800 Byberry Road, Suite 810, Huntingdon Valley, PA 19006
www.ismp.org

FOR IMMEDIATE RELEASE
April 27, 2005
CONTACT: Renee Brehio, Media Relations
704-321-3343, rbrehio@ismp.org

ISMP Launches Self Assessment for Antithrombotic Therapy

HUNTINGDON VALLEY, PA.- The Institute for Safe Medication Practices (ISMP) has developed a new tool designed to assist hospitals in evaluating an important area of clinical practice - antithrombotic therapy. The survey is being distributed to all hospitals in the United States; deadline for data submission is September 1, 2005.

The ISMP Medication Safety Self AssessmentĀ® for Antithrombotic Therapy in Hospitals will help healthcare organizations examine medication safety practices associated with the prescribing, dispensing, administration, and monitoring of antithrombotic drugs in their facilities. Participants will evaluate 125 different characteristics that significantly influence medication safety when patients receive antithrombotic medications, including anticoagulants and thrombolytic agents.

As with ISMP's previous self-assessment surveys, hospitals are being asked to convene multidisciplinary teams to respond and provide a wide range of perspectives for the most complete data set possible. Surveys are completely confidential and the identities of participating organizations will not be revealed. Hospitals are encouraged to submit their data through a secure web-based form, which will allow them to compare their weighted scores with aggregate data from other demographically similar hospitals.

"ISMP's self-assessment for antithrombotics addresses safety issues with a specific class of high-alert drugs, which when involved in errors is more likely to cause serious outcomes," says Matt Fricker, MS, RPh, the program director at ISMP who headed up survey development. "This new self-assessment will allow hospitals to evaluate their practices surrounding the use of antithrombotic therapy, identify opportunities for improvement, and compare their experience with other hospitals across the nation."

Aggregate data is scheduled to be released by early 2006, and will be used to support ISMP's medication safety efforts. For more information and an electronic copy of the antithrombotic self-assessment workbook, visit http://www.ismp.org/Survey/ASA/intro.htm.

About ISMP: The Institute for Safe Medication Practices (ISMP) is a 501c(3) nonprofit organization that works closely with healthcare practitioners and institutions, regulatory agencies, consumers, and professional organizations to provide education about medication errors and their prevention. ISMP represents nearly 30 years of experience in helping healthcare practitioners keep patients safe, and continues to lead efforts to improve the medication use process. In 2004, the Institute celebrated the 10th anniversary of is official incorporation as a nonprofit organization. For more information on ISMP, or its medication safety alert newsletters for healthcare professionals and consumers, visit www.ismp.org

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org.

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

Research Company Seeks Patients who Have Had a Leg Blood Clot (deep vein thrombosis or DVT)

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2014 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-495-4335
Send comments to webmaster@clotcare.org.
Saturday, June 24, 2017